News Archive
More than 30 years ago in Lima, Peru, Elmer Huerta, MD, MPH, newly established director of the Cancer Preventorium Clinic at the George Washington University (GW) Cancer Center and clinical professor of medicine at the GW School of Medicine and Health Sciences (SMHS), entered the emergency room…
Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.
The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University (GW) School of Medicine and Health Sciences and member of the GW Cancer Center, to investigate HIV-1…
Knowing what cancer survivors value can help providers address gaps in care, improve the care experience, and increase behaviors and practices that support survivors’ ability to accept and manage their post-treatment care, according to focus group findings from researchers at the George…
Recognized cancer prevention and control expert Elmer E. Huerta, MD, MPH, will serve as the director of the Cancer Preventorium at the George Washington University (GW) Cancer Center and as professor of medicine at the GW School of Medicine and Health Sciences.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded its first-ever National Institutes of Health T-32 research training grant from the National Cancer Institute (NCI) in support of the GW Cancer Biology Training Program.
Listen as Dr. Mikhail Kogan discusses the benefits of prescribing medical cannabis.
Dr. Yuan James Rao discusses brachytherapy and what to expect from this type of cancer treatment.
Dr. Sharad Goyal, Chief of the GW Radiation Oncology division at the GW Cancer Center, discusses advances in radiosurgery.
Enrollment in a supportive oncodermatology program is associated with a significantly improved quality of life score, according to a recent survey from the George Washington University (GW) Cancer Center. The results of the survey were published in the Journal of Drugs in Dermatology.